Who benefits from plasmapheresis, IVIG, and rituximab in AMR? Development of a clinical decision tree

Rituxan (rituximab) - Roche

Emre Karakaya1; Adem Safak1; Sedat Yildirim1; Alev Ok Atilgan2; Ozgur Ozen3; Mehmet A. Haberal1

Sep 17, 2026